Effects on fibrinolytic activity of corn oil and a fish oil preparation enriched with omega-3-polyunsaturated fatty acids in a long-term study

References

• Andersen P., Nielsen D. W., Lyberg S., Holme I., Hjermann I. Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals. Acta Med. Scand. 1988; 223: 299–3061. Andersen P., Nielsen D. W., Lyberg S., Holme I., Hjermann I. Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals. Acta Med. Scand. 1988; 223: 299–306
   Google Scholar
• Barcelli U., Glas-Grenwalt P., Pollak V. Enhancing effect of dietary supplementation with n-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb. Res. 1985; 39: 307–3122. Barcelli U., Glas-Grenwalt P., Pollak V. Enhancing effect of dietary supplementation with n-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb. Res. 1985; 39: 307–312
   PubMed Web of Science ®Google Scholar
• Boman K. Life style and fibrinolysis. “Clinical Aspects of Fibrinolysis”, T. K. Nilsson, K. Boman, J. H. Jansson. Almqvist and Wiksell Int., Stockholm 1991; 55–663. Boman K. Life style and fibrinolysis. “Clinical Aspects of Fibrinolysis”, T. K. Nilsson, K. Boman, J. H. Jansson. Almqvist and Wiksell Int., Stockholm 1991; 55–66
   Google Scholar
• Chmielewska J., Wiman B. Determination of tissue plasminogen activator and its “fast” inhibitor from plasma. Clin. Chem. 1986; 32: 482–4854. Chmielewska J., Wiman B. Determination of tissue plasminogen activator and its “fast” inhibitor from plasma. Clin. Chem. 1986; 32: 482–485
   PubMed Web of Science ®Google Scholar
• Dalaker K., Smith P., Arnesen H., Prydz H. Factor VII-phospholipid complex in male survivors of acute myocardial infarction. Acta Med. Scand. 1987; 222: 111–1165. Dalaker K., Smith P., Arnesen H., Prydz H. Factor VII-phospholipid complex in male survivors of acute myocardial infarction. Acta Med. Scand. 1987; 222: 111–116
   PubMed Web of Science ®Google Scholar
• Dyerberg J., Bang N. O. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979; 2: 433–4356. Dyerberg J., Bang N. O. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979; 2: 433–435
   PubMed Web of Science ®Google Scholar
• Emeis J., Houwelingen A., van den Hoogen C., Hornstra G. A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. Blood 1989; 74: 233–2377. Emeis J., Houwelingen A., van den Hoogen C., Hornstra G. A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. Blood 1989; 74: 233–237
   PubMed Web of Science ®Google Scholar
• Fröschl H., Spannagl M., Drummer C., Landgraf-Leurs M., Landgraf R., Schramm W. Effect of eicosapentaenoic acid diet on humoral clotting and fibrinolysis parameters in type 1 diabetes mellitus. Haemostasis 1988; 18: 27–28, Suppl. 28. Fröschl H., Spannagl M., Drummer C., Landgraf-Leurs M., Landgraf R., Schramm W. Effect of eicosapentaenoic acid diet on humoral clotting and fibrinolysis parameters in type 1 diabetes mellitus. Haemostasis 1988; 18: 27–28, Suppl. 2
   Google Scholar
• Hamsten A., DeFaire U., Walldius G., Dahlén G., Szamosi A., Landou C., Blombäck M., Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3–99. Hamsten A., DeFaire U., Walldius G., Dahlén G., Szamosi A., Landou C., Blombäck M., Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3–9
   PubMed Web of Science ®Google Scholar
• Hansen J. B., Olsen J. O., Wilsgård B., Østerud B. Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J. Int. Med. 1989; 225: 133–139, Suppl. 110. Hansen J. B., Olsen J. O., Wilsgård B., Østerud B. Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J. Int. Med. 1989; 225: 133–139, Suppl. 1
   Web of Science ®Google Scholar
• Huhtasaari F., Asplund K., Wester P. O. Cardiovascular risk factors in the northern Swedish MONICA study. Acta Med. Scand. 1988; 224: 99–10811. Huhtasaari F., Asplund K., Wester P. O. Cardiovascular risk factors in the northern Swedish MONICA study. Acta Med. Scand. 1988; 224: 99–108
   PubMed Web of Science ®Google Scholar
• Jansson J. H. The fibrinolytic system in ischaemic heart disease. “Clinical Aspects of Fibrinolysis”, T. K. Nilsson, K. Boman, J. H. Jansson. Almqvist & Wiksell Int., Stockholm 1991; 95–11012. Jansson J. H. The fibrinolytic system in ischaemic heart disease. “Clinical Aspects of Fibrinolysis”, T. K. Nilsson, K. Boman, J. H. Jansson. Almqvist & Wiksell Int., Stockholm 1991; 95–110
   Google Scholar
• Jansson J. H., Nilsson T. K., Olofsson B. O. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur. Heart J. 1991; 12: 157–16113. Jansson J. H., Nilsson T. K., Olofsson B. O. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur. Heart J. 1991; 12: 157–161
   PubMed Web of Science ®Google Scholar
• Mehta J., Lawson D., Saldeen T. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3-polyunsaturated fatty acids (PUFA) intake. Am. Heart J. 1988; 116: 1201–120614. Mehta J., Lawson D., Saldeen T. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3-polyunsaturated fatty acids (PUFA) intake. Am. Heart J. 1988; 116: 1201–1206
   PubMed Web of Science ®Google Scholar
• Müllertz A., Holmer G., Gröndal-Hansen J. Increased concentration of plasminogen activator inhibitor type-1 in plasma after intake of fish oil. Fibrinolysis 1990; 4: 86–88, Suppl. 215. Müllertz A., Holmer G., Gröndal-Hansen J. Increased concentration of plasminogen activator inhibitor type-1 in plasma after intake of fish oil. Fibrinolysis 1990; 4: 86–88, Suppl. 2
   Google Scholar
• Nilsson T. K., Mellbring G. Impact of immediate acidification of blood on measurement of plasma tissue plasminogen activator (tPA) activity in surgical patients. Clin. Chem. 1989; 35: 199916. Nilsson T. K., Mellbring G. Impact of immediate acidification of blood on measurement of plasma tissue plasminogen activator (tPA) activity in surgical patients. Clin. Chem. 1989; 35: 1999
   PubMed Web of Science ®Google Scholar
• Rånby M., Bergsdorf N., Nilsson T., Mellbring G., Winblad B., Bucht G. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin. Chem. 1986; 32: 2160–216517. Rånby M., Bergsdorf N., Nilsson T., Mellbring G., Winblad B., Bucht G. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin. Chem. 1986; 32: 2160–2165
   PubMed Web of Science ®Google Scholar
• Rånby M., Sundell I. B., Nilsson T. K. Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb. Haemostas. 1989; 62: 917–92218. Rånby M., Sundell I. B., Nilsson T. K. Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb. Haemostas. 1989; 62: 917–922
   PubMed Web of Science ®Google Scholar
• Sanders T., Vickers M., Haines A. Effects on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and docosahexaenoic acids, in healthy young men. Clin. Sci. 1981; 61: 317–32419. Sanders T., Vickers M., Haines A. Effects on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and docosahexaenoic acids, in healthy young men. Clin. Sci. 1981; 61: 317–324
   PubMed Web of Science ®Google Scholar
• Schmidt E., Kristensen S., Dyerberg J. The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. Artery 1988; 15: 316–32920. Schmidt E., Kristensen S., Dyerberg J. The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. Artery 1988; 15: 316–329
   PubMedGoogle Scholar
• Schmidt E., Ernst E., Varming K., Pedersen J., Dyerberg J. The effect of n-3 fatty acids on lipids and haemostasis in patients with type IIa and type IV hyperlipidemia. Thromb. Haemostas. 1989; 62: 797–80121. Schmidt E., Ernst E., Varming K., Pedersen J., Dyerberg J. The effect of n-3 fatty acids on lipids and haemostasis in patients with type IIa and type IV hyperlipidemia. Thromb. Haemostas. 1989; 62: 797–801
   PubMed Web of Science ®Google Scholar
• Sundell I. B., Nilsson T. K., Rånby M., Hallmans G., Hellsten G. Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjö, Sweden. J. Clin. Epidemiol. 1989; 42: 719–72322. Sundell I. B., Nilsson T. K., Rånby M., Hallmans G., Hellsten G. Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjö, Sweden. J. Clin. Epidemiol. 1989; 42: 719–723
   PubMed Web of Science ®Google Scholar
• Takimoto G., Galang J., Lee G. K., Bradlow B. A. Plasma fibrinolytic activity after ingestion of omega-3 fatty acids in human subjects. Thromb. Res. 1989; 54: 573–58223. Takimoto G., Galang J., Lee G. K., Bradlow B. A. Plasma fibrinolytic activity after ingestion of omega-3 fatty acids in human subjects. Thromb. Res. 1989; 54: 573–582
   PubMed Web of Science ®Google Scholar
• Weber P. C. Atherosclerosis risk factor modification by n-3 fatty acids. Atherosclerosis Rev. 1990; 21: 91–10224. Weber P. C. Atherosclerosis risk factor modification by n-3 fatty acids. Atherosclerosis Rev. 1990; 21: 91–102
   Google Scholar
• Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Hbrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 1984; 311: 501–50525. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Hbrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 1984; 311: 501–505
   PubMed Web of Science ®Google Scholar
• Wiman B., Mellbring G., Rinby M. Plasminogen activator release during venous stasis and exercise determined by a new specific assay. Clin. Chim. Acta 1983; 127: 279–28826. Wiman B., Mellbring G., Rinby M. Plasminogen activator release during venous stasis and exercise determined by a new specific assay. Clin. Chim. Acta 1983; 127: 279–288
   PubMed Web of Science ®Google Scholar
• Zucker M., Bilyeu D., Helmkamp G., Harris W., Dujovne C. Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects. Atherosclerosis 1988; 73: 13–2227. Zucker M., Bilyeu D., Helmkamp G., Harris W., Dujovne C. Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects. Atherosclerosis 1988; 73: 13–22
   PubMed Web of Science ®Google Scholar